The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its geographic reach.
Private equity firms back PCI Pharma in bet on drug production
The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its geographic reach.